Skip to main content
NewslettersWatchlist

Bausch Health Companies Inc(BHC-T)
TSX

Today's Change
Real-Time Last Update
Day Low11.94
Day High12.27
Open:12.27
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
AI-generated - The Globe and Mail
Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC)
AI-generated - The Globe and Mail
Bausch Health Companies: Stocks Overvalued by Analyst Consensus on TSX (BHC)
AI-generated - The Globe and Mail
Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC)
AI-generated - The Globe and Mail
Bausch Health Companies: Stocks Overvalued by Analyst Consensus on TSX (BHC)
ACCESSWIRE
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Newswire.ca
Investor Alert and Limitation Period: Canadian investors that purchased shares of Bausch Health Companies, Inc. listed on the Toronto Stock Exchange need to act
The Globe and Mail
The most oversold and overbought stocks on the TSX
Baystreet
TSX Has Winning Week Despite Friday Stumble
Baystreet
Cut in Rates in U.S. Weighs on TSX
Baystreet
Stocks in play: Bausch Health Companies Inc.
ACCESSWIRE
Health Canada Approves (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and Older
The Globe and Mail
Wednesday’s analyst upgrades and downgrades
The Globe and Mail
Friday’s analyst upgrades and downgrades
Baystreet
TSX Loses Out Wednesday
ACCESSWIRE
Bausch Health Responds to Market Rumors
AI-generated - The Globe and Mail
Bausch Health Companies: Top 10 Undervalued Healthcare Sector Stocks on TSX (BHC)
Baystreet
Stocks Stumble Following Jobs Numbers
Baystreet
Stocks Dive at Noon
AI-generated - The Globe and Mail
Bausch Health Companies: Top 10 Undervalued Mid Cap Stocks on TSX (BHC)
AI-generated - The Globe and Mail
Bausch Health Companies: Top 10 Undervalued Mid Cap Stocks on TSX (BHC)
AI-generated - The Globe and Mail
Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC)
Baystreet
Markets Finish Day on Upswing

Profile

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.